120 related articles for article (PubMed ID: 33311590)
21. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
Zhang X; Bai J; Yin H; Long L; Zheng Z; Wang Q; Chen F; Yu X; Zhou Y
Mol Oncol; 2020 Oct; 14(10):2589-2608. PubMed ID: 32679610
[TBL] [Abstract][Full Text] [Related]
22. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.
Kim SL; Lee ST; Min IS; Park YR; Lee JH; Kim DG; Kim SW
Cancer Sci; 2017 Nov; 108(11):2176-2186. PubMed ID: 28859238
[TBL] [Abstract][Full Text] [Related]
23. GDF15 promotes EMT and metastasis in colorectal cancer.
Li C; Wang J; Kong J; Tang J; Wu Y; Xu E; Zhang H; Lai M
Oncotarget; 2016 Jan; 7(1):860-72. PubMed ID: 26497212
[TBL] [Abstract][Full Text] [Related]
24. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
25. ZNF326 promotes colorectal cancer epithelial-mesenchymal transition.
Yang Y; Yan T; Han Q; Zhang M; Zhang Y; Luo Y; Wei L; Li P; Wang E
Pathol Res Pract; 2021 Sep; 225():153554. PubMed ID: 34332402
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
Zafari N; Velayati M; Nassiri M; Khazaei M; Hassanian SM; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(28):2298-2311. PubMed ID: 35909286
[TBL] [Abstract][Full Text] [Related]
27. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
[TBL] [Abstract][Full Text] [Related]
29. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
30. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
31. Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer.
Kouso H; Yano T; Maruyama R; Shikada Y; Okamoto T; Haro A; Kakeji Y; Maehara Y
Surg Today; 2013 Jan; 43(1):73-80. PubMed ID: 23052737
[TBL] [Abstract][Full Text] [Related]
32. Degradation of HIF-1α induced by curcumol blocks glutaminolysis and inhibits epithelial-mesenchymal transition and invasion in colorectal cancer cells.
Bian Y; Yin G; Wang G; Liu T; Liang L; Yang X; Zhang W; Tang D
Cell Biol Toxicol; 2023 Oct; 39(5):1957-1978. PubMed ID: 35083610
[TBL] [Abstract][Full Text] [Related]
33. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
34. Up-frameshift Protein 1 Promotes Tumor Progression by Regulating Apoptosis and Epithelial-Mesenchymal Transition of Colorectal Cancer.
Chen B; Wang H; Li D; Lin X; Ma Z; Zeng Y
Technol Cancer Res Treat; 2021; 20():15330338211064438. PubMed ID: 34939866
[No Abstract] [Full Text] [Related]
35. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
36. PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Steller EJ; Raats DA; Koster J; Rutten B; Govaert KM; Emmink BL; Snoeren N; van Hooff SR; Holstege FC; Maas C; Borel Rinkes IH; Kranenburg O
Neoplasia; 2013 Feb; 15(2):204-17. PubMed ID: 23441134
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α.
Zhang W; Yuan W; Song J; Wang S; Gu X
Biochimie; 2018 Jan; 144():21-27. PubMed ID: 29017924
[TBL] [Abstract][Full Text] [Related]
38. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
Kaller M; Hermeking H
Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
[TBL] [Abstract][Full Text] [Related]
40. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
